ABCL logo

AbCellera Biologics (ABCL) Operating profit

annual operating profit:

-$301.15M-$78.09M(-35.01%)
December 31, 2024

Summary

  • As of today (June 13, 2025), ABCL annual operating income is -$301.15 million, with the most recent change of -$78.09 million (-35.01%) on December 31, 2024.
  • During the last 3 years, ABCL annual operating profit has fallen by -$523.04 million (-235.71%).
  • ABCL annual operating profit is now -232.63% below its all-time high of $227.06 million, reached on December 31, 2022.

Performance

ABCL Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

quarterly operating profit:

-$58.51M+$10.70M(+15.47%)
March 31, 2025

Summary

  • As of today (June 13, 2025), ABCL quarterly operating income is -$58.51 million, with the most recent change of +$10.70 million (+15.47%) on March 31, 2025.
  • Over the past year, ABCL quarterly operating profit has dropped by -$6.89 million (-13.34%).
  • ABCL quarterly operating profit is now -125.42% below its all-time high of $230.14 million, reached on March 31, 2022.

Performance

ABCL quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

TTM operating profit:

-$308.03M-$6.89M(-2.29%)
March 31, 2025

Summary

  • As of today (June 13, 2025), ABCL TTM operating income is -$308.03 million, with the most recent change of -$6.89 million (-2.29%) on March 31, 2025.
  • Over the past year, ABCL TTM operating profit has dropped by -$94.86 million (-44.50%).
  • ABCL TTM operating profit is now -188.00% below its all-time high of $350.03 million, reached on September 30, 2022.

Performance

ABCL TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ABCL Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.0%-13.3%-44.5%
3 y3 years-235.7%-125.4%-205.9%
5 y5 years-10000.0%-5257.8%-10000.0%

ABCL Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-232.6%at low-125.4%+35.1%-188.0%at low
5 y5-year-232.6%at low-125.4%+35.1%-188.0%at low
alltimeall time-232.6%at low-125.4%+35.1%-188.0%at low

ABCL Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$58.51M(-15.5%)
-$308.03M(+2.3%)
Dec 2024
-$301.15M(+35.0%)
-$69.21M(-23.2%)
-$301.15M(+2.2%)
Sep 2024
-
-$90.17M(+0.0%)
-$294.61M(+14.9%)
Jun 2024
-
-$90.14M(+74.6%)
-$256.50M(+20.3%)
Mar 2024
-
-$51.62M(-17.6%)
-$213.17M(-4.4%)
Dec 2023
-$223.05M(-198.2%)
-$62.68M(+20.4%)
-$223.05M(+13.5%)
Sep 2023
-
-$52.06M(+11.2%)
-$196.48M(+88.0%)
Jun 2023
-
-$46.81M(-23.9%)
-$104.53M(+61.9%)
Mar 2023
-
-$61.50M(+70.3%)
-$64.58M(-128.4%)
Dec 2022
$227.06M
-$36.10M(-190.5%)
$227.06M(-35.1%)
Sep 2022
-
$39.88M(-681.3%)
$350.03M(+22.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$6.86M(-103.0%)
$286.43M(-1.5%)
Mar 2022
-
$230.14M(+164.9%)
$290.91M(+31.0%)
Dec 2021
$221.90M(+35.0%)
$86.86M(-466.3%)
$221.98M(-24.5%)
Sep 2021
-
-$23.72M(+893.5%)
$294.00M(-7.3%)
Jun 2021
-
-$2.39M(-101.5%)
$317.28M(-2.9%)
Mar 2021
-
$161.22M(+1.5%)
$326.67M(+98.8%)
Dec 2020
$164.35M(-7114.6%)
$158.88M(<-9900.0%)
$164.35M(+3976.4%)
Sep 2020
-
-$431.00K(-106.2%)
$4.03M(-9.7%)
Jun 2020
-
$7.00M(-740.7%)
$4.46M(-276.2%)
Mar 2020
-
-$1.09M(-24.2%)
-$2.53M(+75.8%)
Dec 2019
-$2.34M(-378.6%)
-$1.44M
-$1.44M
Dec 2018
$841.00K
-
-

FAQ

  • What is AbCellera Biologics annual operating income?
  • What is the all time high annual operating profit for AbCellera Biologics?
  • What is AbCellera Biologics annual operating profit year-on-year change?
  • What is AbCellera Biologics quarterly operating income?
  • What is the all time high quarterly operating profit for AbCellera Biologics?
  • What is AbCellera Biologics quarterly operating profit year-on-year change?
  • What is AbCellera Biologics TTM operating income?
  • What is the all time high TTM operating profit for AbCellera Biologics?
  • What is AbCellera Biologics TTM operating profit year-on-year change?

What is AbCellera Biologics annual operating income?

The current annual operating profit of ABCL is -$301.15M

What is the all time high annual operating profit for AbCellera Biologics?

AbCellera Biologics all-time high annual operating income is $227.06M

What is AbCellera Biologics annual operating profit year-on-year change?

Over the past year, ABCL annual operating income has changed by -$78.09M (-35.01%)

What is AbCellera Biologics quarterly operating income?

The current quarterly operating profit of ABCL is -$58.51M

What is the all time high quarterly operating profit for AbCellera Biologics?

AbCellera Biologics all-time high quarterly operating income is $230.14M

What is AbCellera Biologics quarterly operating profit year-on-year change?

Over the past year, ABCL quarterly operating income has changed by -$6.89M (-13.34%)

What is AbCellera Biologics TTM operating income?

The current TTM operating profit of ABCL is -$308.03M

What is the all time high TTM operating profit for AbCellera Biologics?

AbCellera Biologics all-time high TTM operating income is $350.03M

What is AbCellera Biologics TTM operating profit year-on-year change?

Over the past year, ABCL TTM operating income has changed by -$94.86M (-44.50%)
On this page